Clinical Trial
Published on 29 Apr 2026
Safety, tolerability, pharmacokinetics, and pharmacodynamics of LW402, a preferential Janus kinase 1 inhibitor in healthy volunteers: a randomized, double-blinded, placebo-controlled phase 1 trial
in Translational Pharmacology
- 175 views